1.62
9.46%
0.14
Handel nachbörslich:
1.64
0.02
+1.23%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ONCT?
Forum
Prognose
Aktiensplit
Finanzdaten der Oncternal Therapeutics Inc-Aktie (ONCT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
91.58%
0.569
|
0.297 | 0.179 | 0.106 | 0.203 |
Operating Expenses |
5.89%
9.348
|
9.933 | 10.57 | 9.651 | 12.35 |
Benefits Costs and Expenses |
5.33%
8.957
|
9.461 | - | - | 11.69 |
Costs And Expenses |
5.33%
8.957
|
9.461 | 10.57 | 9.651 | 11.69 |
Operating Income/Loss |
8.89%
-8.779
|
-9.636 | -10.39 | -9.545 | -12.14 |
Income/Loss From Continuing Operations Before Tax |
8.47%
-8.388
|
-9.164 | 0.179 | 0.106 | -11.49 |
Income/Loss From Continuing Operations After Tax |
8.47%
-8.388
|
-9.164 | -9.862 | -8.966 | -11.49 |
Net Income/Loss
|
8.47%
-8.388
|
-9.164 | -9.862 | -8.966 | -11.49 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
105.30%
2.959
|
-55.80 | 58.96 | 58.72 | 58.52 |
Diluted Average Shares |
105.30%
2.959
|
-55.80 | 58.96 | 58.72 | 58.52 |
Basic Earnings Per Share |
78.08%
-2.83
|
-12.91 | -0.17 | -0.15 | -0.20 |
Diluted Earnings Per Share |
78.08%
-2.83
|
-12.91 | -0.17 | -0.15 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):